Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG39744

DPYSL3 Knockout HEK293T Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Kidney

DPYSL3 Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited knockout population disrupting the DPYSL3 (CRMP4) gene in HEK293T human embryonic kidney cells. DPYSL3 mediates Semaphorin 3A?Cdriven cytoskeletal reorganization and interacts with tubulin, actin, and CRMP1/2. This polyclonal pool enables loss-of-function studies in semaphorin signaling, axon guidance, and tumor cell migration. The HEK293T background offers robust transfection and protein expression, making these cells ideal for pathway reconstitution, small-molecule screening, and functional assays such as western blotting, immunofluorescence, and migration assays. Researchers can use this model to dissect DPYSL3-dependent cytoskeletal dynamics and screen for signaling modifiers.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HEK293T

    Sex of Donor

    Female

    Age

    Fetus

    Derived From Site

    Fetal kidney

    Gene Name

    DPYSL3

    Gene Identifier

    NCBI Gene ID 1809

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    DMEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The DPYSL3 Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population produced by disrupting the DPYSL3 gene in HEK293T host cells. This heterogeneous pool of knockout cells provides a loss-of-function model to study the roles of DPYSL3 (also known as collapsin response mediator protein 4, CRMP4) in semaphorin signaling, cytoskeletal regulation, and related cellular processes. The polyclonal format captures a spectrum of gene-edited alleles, avoiding clonal selection artifacts, and represents a versatile tool for pathway analysis and functional screening.

The host cell line, HEK293T, is an SV40 large T-antigen-transformed human embryonic kidney epithelial cell line. It grows adherently and is widely adopted for its high transfection efficiency and robust protein expression capabilities. HEK293T cells are a standard platform for recombinant protein production, lentiviral packaging, and transient expression assays. Their amenability to genetic manipulation and established use in signal transduction studies make them a suitable background for dissecting the DPYSL3 signaling axis.

DPYSL3/CRMP4 is a phosphoprotein that mediates semaphorin-induced axon guidance and cytoskeletal reorganization. Upon activation by Semaphorin 3A (Sema3A) through the Neuropilin-1/Plexin-A receptor complex, DPYSL3 is regulated by upstream kinases including GSK-3?? and Cdk5. It interacts with cytoskeletal components such as tubulin and actin, as well as family members CRMP1 and CRMP2, the kinase GSK-3??, and the tyrosine kinase Fyn. Downstream, DPYSL3 modulates microtubule polymerization, actin dynamics, cell adhesion, and migration. It functions within a network that includes Rho GTPases to control growth cone collapse and neuronal polarity.

In the HEK293T context, loss of DPYSL3 disrupts the semaphorin signaling cascade, providing a clean background to study ligand-dependent cytoskeletal changes. Although HEK293T cells are of non-neuronal origin, they express many core signaling components and are permissive for ectopic expression of neuronal receptors, enabling reconstitution of axon guidance pathways. This knockout pool is particularly relevant for investigating cancer cell migration, as DPYSL3 has been implicated in tumor invasion and metastasis. The polyclonal nature allows researchers to assess population-level responses while circumventing clonal biases.

This knockout model supports a wide range of experimental approaches. Western blotting and RT-qPCR confirm the absence of DPYSL3 protein and mRNA, respectively. Immunofluorescence can visualize altered cytoskeletal organization, while cell migration and invasion assays quantitatively assess functional consequences. Phospho-signaling analysis following Sema3A stimulation reveals pathway activation defects. Typical applications include screening for modifiers of semaphorin signaling, investigating CRMP4-dependent tumor cell motility, and modeling neurodevelopmental disturbances. For further details or to inquire about this product, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)